Navigation Links
ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
Date:10/30/2007

a higher clinical success rate than patients on metronidazole or the investigational compound. These data confirm the efficacy and safety of Vancocin in patients with severe CDAD and we expect that these data and the IDSA/SHEA guidelines for treatment of CDAD will be strongly considered in treatment recommendations."

Net income in the third quarter and nine-months ended September 30, 2007 was $21.3 million and $75.0 million, respectively, compared to a net income of $23.3 million and $48.7 million for the same periods in 2006. Net income per share for the quarter ended September 30, 2007 was $0.30 per share, basic and $0.26 per share, diluted, compared to a net income of $0.34 per share, basic, and $0.33 per share, diluted, for the same period in 2006. Net income per share for the nine-months ended September 30, 2007 was $1.07 per share, basic, and $0.96 per share, diluted, compared to a net income of $0.71 per share, basic, and $0.69 per share, diluted, for the same period in 2006.

The primary drivers of the change in net income for the third quarter were the effects of decreased operating income discussed above, offset by increased interest income and a lower effective tax rate. Net income for the nine month period increased primarily due to higher net sales.

Operating Highlights

During the three and nine months ended September 30, 2007, net sales of Vancocin decreased 7.6 percent and increased 21.8 percent, respectively, compared to the same periods in 2006. The decrease in net sales of 7.6 percent resulted from fewer units sold to wholesalers in the third quarter of 2007 than during the third quarter of 2006 as a result of wholesaler buyer decisions to increase inventory levels in the third quarter of 2006. The nine month increase of 21.8 percent resulted from an increase in units sold to wholesalers and the impact of a price increase in 2007.

The gross product margin rate (net product sales less cost of sales as a percent of net pr
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Autopsy reports could be valuable and informative
3. China reports declining number of SARS Cases
4. Russia Reports First SARS Case
5. Research reports that c-section deliveries are rising
6. Jharkhand reports 13,000 Malaria cases
7. Uganda Reports Failure To Contain Sleeping Sickness
8. WHO reports 36 million deaths world wide due to chronic diseases
9. Reports of Hantavirus infection in India raise concerns
10. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
11. China Reports Yet Another Bird Flu Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... Daily Gossip reveals in its review a ... You program, who shows a unique formula to get inside ... method says that the program goes beyond mere attraction and ... You review indicates that the program was created by dating ... great techniques to make a man feel emotionally addicted. , ...
(Date:8/30/2014)... York (PRWEB) August 30, 2014 ... of Nutrition and Pharameuticals. Nutraceuticals is a source ... healthy ingredients from natural food sources. Nutraceutical ingredients ... benefits to the human body. Nutraceutical health products ... supplements, fortified foods and more. Although nature is ...
(Date:8/30/2014)... 2014 After offering hyperbaric oxygen ... the past several years, Dr. Roy Schmidt and ... announced a scholarship program for veterans who have ... meeting held this summer to discuss veterans’ needs ... have shed light on the large number of ...
(Date:8/30/2014)... August 30, 2014 Hundreds of Byetta ... continue to move forward in U.S. courts, Bernstein Liebhard ... PLC on July 31, 2014, Byetta and Bydureon (an ... product liability claims that allege the drugs caused pancreatitis, ... many of these claims are pending in a multidistrict ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has ... sleep apnea (a medical problem where the airway collapses during ... of the rest they need to face their daily challenges. ... 20 million people in the United States alone have sleep ... and of those treated, many cannot tolerate their prescribed medical ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Star Scientific, Inc. (Nasdaq: STSI ) filed ... Securities and Exchange Commission. The company reported 2008 net ... net sales for 2007. However, volume sales of the ... increased 7.8% in 2008 compared to 2007. The wholesale ...
... From ,Democracy to Despotism, Cardinal Francis George WarnsAlert ... ProtectionsWASHINGTON, March 16 Cardinal Francis George is ... the Obama Administration to retain Health and Human ... workers.This is vital to keep the government from ...
... among Top 10 Companies for Supplier Diversity and for African ... Service Corporation (HCSC) as one of its Top 50 Companies ... In 2009, the company ranks 22, up 12 spots from ... 10 Companies for Supplier Diversity as well as the Top ...
... March 16 Coursework begins today as the American ... states to deliver needed dental care to underserved people ... developed by the ADA over the past several years, ... Dental Health Coordinator (CDHC). CDHCs are drawn from the ...
... Access to Medigap as Additional Coverage Option For ... 16 The National Kidney Foundation of Florida ... Representative Ritch Workman today for co-sponsoring proposed legislation ... for Florida,s end stage renal disease (ESRD) patients ...
... suggests close monitoring offers some men better quality of ... immediate treatment can be safe for men with low-risk ... finds. , The multi-center study of American and Canadian ... or if to treat men with low-risk prostate cancer ...
Cached Medicine News:Health News:Star Scientific Files Annual Financial Report 2Health News:Star Scientific Files Annual Financial Report 3Health News:Star Scientific Files Annual Financial Report 4Health News:Cardinal George Urges Catholics to Tell Administration: Keep Conscience Protections for Health Care Workers 2Health News:Cardinal George Urges Catholics to Tell Administration: Keep Conscience Protections for Health Care Workers 3Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 2Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 3Health News:Health Care Service Corporation Ranked as One of the Most Diverse Companies in the Country for 5th Consecutive Year 4Health News:ADA Launches Community Dental Health Coordinator Program to Provide Dental Care in Underserved Areas 2Health News:ADA Launches Community Dental Health Coordinator Program to Provide Dental Care in Underserved Areas 3Health News:The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring 'Common Sense' Legislation Widely Hailed as 'Good for Patients, Good for Taxpayers, Good for Florida' 2Health News:'Watchful Waiting' Safe With Low-Risk Prostate Cancers 2
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... Aug. 29, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the CL ... on Tuesday, September 9, 2014 at 12:30 p.m. ET. ... Place Hotel in New York City ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3
... CARLSBAD, Calif., Nov. 22, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... up to $14 million from Pfizer Inc. (NYSE: ... from Pfizer,s acquisition of Excaliard.  Upon closing of the acquisition, ... up to an additional $9.6 million could be paid to ...
... NEW YORK, Nov. 22, 2011 ... research report is available in its ... - Global Pipeline Analysis, Competitive Landscape ... http://www.reportlinker.com/p0685952/X-Ray-Systems---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...
Cached Medicine Technology:Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals 2Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals 3Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals 4X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12X-Ray Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13
Anterior Chamber Needle, 30 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Anterior Chamber Needle, 23 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 20 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Medicine Products: